Story thread · 4 reports / 4 sources

Ibogaine could rise as potential psychedelic treatment with Trump announcement

seekingalpha.com · 4h · first report

The coverage

  1. Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development

    financialpost.com · 54m

  2. Psyence Biomedical stock surges on Trump ibogaine announcement

    investing.com · 2h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.